{"id":144048,"date":"2025-01-16T18:00:30","date_gmt":"2025-01-16T17:00:30","guid":{"rendered":"https:\/\/www.startupbusiness.it\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/"},"modified":"2025-01-17T11:47:39","modified_gmt":"2025-01-17T10:47:39","slug":"indaco-venture-invests-in-tes-pharmas-e15-million-round","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/","title":{"rendered":"Indaco Venture invests in Tes Pharma&#8217;s \u20ac15 million round"},"content":{"rendered":"\n<p><strong>Indaco Venture Partners reports that it has joined the Series A round of Tes Pharma, a biotechnology company specialising in the development of innovative therapies for unmet medical needs in oncology, kidney and metabolic diseases.<\/strong> Indaco&#8217;s entry into the round, previously led by XGEN Venture, brings the total raised to <strong>EUR 15m.<\/strong> <\/p>\n\n<p>The funding aims to support the development of TES-AKI-01, the company&#8217;s drug candidate for the treatment of acute kidney failure (AKI), and other pipeline programmes for the treatment of metabolic and oncological diseases.<\/p>\n\n<p>AKI is a critical condition characterised by a sudden decline in kidney function, with approximately 100 million cases reported globally each year and no currently approved therapy. AKI is a life-threatening condition for patients, complicating up to 50 per cent of hospital admissions requiring intensive care. Early intervention and effective prevention strategies are essential to improve patients&#8217; clinical response and reduce the long-term impact on renal health. AKI and other renal diseases have been associated with NAD+ depletion. TES-AKI-01 recovers NAD+ levels and restores essential cellular pathways linked to mitochondrial dysfunction in the kidney. TES-AKI-01 demonstrated a strong protective effect in AKI-relevant animal models.     <\/p>\n\n<p><strong>Giovanni Rizzo, partner at Indaco BIO Fund says in a note: \u2018Tes is a team-based company with enormous knowledge in drug discovery and development and brings with it a pipeline of products for clinical indications ranging from cellular metabolism to cancer<\/strong>. With this round we expect to accelerate the development of a drug that in the first instance can help patients with AKI\u2019. <\/p>\n\n<p><strong>Davide Turco, co-founder and CEO of Indaco SGR, adds: \u2018The investment in Tes Pharma represents further confirmation of our commitment to support promising companies in the biotechnology sector.<\/strong> The Indaco Bio fund is going through a particularly intense period: the Tes Pharma transaction is just the first in a series of new investments that will be announced in the coming weeks. These initiatives testify to our commitment to the constant search for innovative solutions that can offer both high returns and significant contributions to improving people&#8217;s quality of life&#8217;. <\/p>\n\n<p><strong>\u2018The support of XGEN and Indaco, investors specialised in biotechnology, testifies to our pioneering approach in the development of innovative therapies for diseases with high unmet needs,\u2019 says Luca Benatti, CEO of Tes Pharma.<\/strong> \u2019Thanks to our recent discoveries, this investment allows us to accelerate the development of our core programmes towards significant milestones. <em>(photo by <a href=\"https:\/\/unsplash.com\/it\/@ashraful25?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash\">Ashraful Islam<\/a> on <a href=\"https:\/\/unsplash.com\/it\/foto\/un-doppio-filo-di-spirali-blu-e-bianche-pRt3JVYlJho?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash\">Unsplash<\/a>)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases<\/p>\n","protected":false},"author":125,"featured_media":144033,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[1473,1137,1136,1145],"companies":[2402,2401],"journalist":[1518],"class_list":["post-144048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-biotechnology","tag-italy-en","tag-startup-en-2","tag-venture-capital-en-2","companies-indaco-venture-partners-en","companies-tes-pharma-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","width":150,"height":84,"crop":false,"srcset":false,"alt":"biotecnologie"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","width":1024,"height":576,"crop":false,"srcset":false,"alt":"biotecnologie"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","width":2048,"height":1152,"crop":false,"srcset":false,"alt":"biotecnologie"}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Indaco Venture invests in Tes Pharma&#039;s \u20ac15 million round<\/title>\n<meta name=\"description\" content=\"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indaco Venture invests in Tes Pharma&#039;s \u20ac15 million round\" \/>\n<meta property=\"og:description\" content=\"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T17:00:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-17T10:47:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"3840\" \/>\n\t<meta property=\"og:image:height\" content=\"2160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"Indaco Venture invests in Tes Pharma&#8217;s \u20ac15 million round\",\"datePublished\":\"2025-01-16T17:00:30+00:00\",\"dateModified\":\"2025-01-17T10:47:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/\"},\"wordCount\":411,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/ashraful-islam-pRt3JVYlJho-unsplash.webp\",\"keywords\":[\"Biotechnology\",\"italy\",\"startup\",\"venture capital\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/\",\"name\":\"Indaco Venture invests in Tes Pharma's \u20ac15 million round\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/ashraful-islam-pRt3JVYlJho-unsplash.webp\",\"datePublished\":\"2025-01-16T17:00:30+00:00\",\"dateModified\":\"2025-01-17T10:47:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-venture-invests-in-tes-pharmas-e15-million-round\\\/144048\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/ashraful-islam-pRt3JVYlJho-unsplash.webp\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/ashraful-islam-pRt3JVYlJho-unsplash.webp\",\"width\":3840,\"height\":2160,\"caption\":\"biotecnologie\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indaco Venture invests in Tes Pharma's \u20ac15 million round","description":"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/","og_locale":"en_US","og_type":"article","og_title":"Indaco Venture invests in Tes Pharma's \u20ac15 million round","og_description":"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases","og_url":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/","og_site_name":"Startupbusiness.it","article_published_time":"2025-01-16T17:00:30+00:00","article_modified_time":"2025-01-17T10:47:39+00:00","og_image":[{"width":3840,"height":2160,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","type":"image\/webp"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"Indaco Venture invests in Tes Pharma&#8217;s \u20ac15 million round","datePublished":"2025-01-16T17:00:30+00:00","dateModified":"2025-01-17T10:47:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/"},"wordCount":411,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","keywords":["Biotechnology","italy","startup","venture capital"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/","url":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/","name":"Indaco Venture invests in Tes Pharma's \u20ac15 million round","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","datePublished":"2025-01-16T17:00:30+00:00","dateModified":"2025-01-17T10:47:39+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-venture-invests-in-tes-pharmas-e15-million-round\/144048\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/01\/ashraful-islam-pRt3JVYlJho-unsplash.webp","width":3840,"height":2160,"caption":"biotecnologie"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=144048"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144048\/revisions"}],"predecessor-version":[{"id":144049,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144048\/revisions\/144049"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/144033"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=144048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=144048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=144048"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=144048"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=144048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}